working out on tirzepatide FEELS SO GOOD TO FINALLY SEE RESULTS AFTER 8 MONTHS OF BEING IT. #tirzepatide Tirzepatide Weight Loss Program- 8

Compared with other GLP-1RAs, treatment with semaglutide or tirzepatide was not associated with risk of NAION (HR, 1.75 [95% CI, 0.98-3.10]) but was associated with increased risk of other optic nerve disorders (HR, 1.94 [95% CI, 1.32-2.85]) and other optical disc orders (HR, 1.39 [95% CI, 1.00-1.93]) (Figure 4)

There is time to discuss whether a GLP-1 makes sense for your specific situation, monitor side effects, manage dose escalations, and adjust if something is not working

For fat / obese patients, the research was more shocking indicating 20 NAION events in the semaglutide cohort as opposed to 3 in the non-GLP-1 RA cohort, indicating a hazard ratio of 7.64

En pacientes con retinopata diabtica, se recomienda monitorizacin oftalmolgica regular, ya que la mejora rpida del control glucmico puede asociarse con empeoramiento temporal de la retinopata